Lv22
130 积分 2024-12-04 加入
Innovative therapies in rheumatoid arthritis: CAR T cells and bispecific antibodies
19小时前
待确认
Innovative therapies in rheumatoid arthritis: CAR T cells and bispecific antibodies
20小时前
已关闭
Bispecific T cell engager therapy for refractory rheumatoid arthritis
21小时前
已完结
SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial
1个月前
已完结
Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system
1个月前
已完结
Overcoming multidrug resistance in gastrointestinal cancers with a CDH17-targeted ADC conjugated to a DNA topoisomerase inhibitor
1个月前
已完结
A phase 1, first-in-human study of AMT-676, an anti-CDH17 antibody-drug conjugate, in patients with advanced gastrointestinal tumors
2个月前
已关闭
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
3个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
3个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
5个月前
已完结
皖公网安备34019202002308
